Cargando…
Responder Profile to Pharmaceutical-Grade Chondroitin Sulfate: An Analysis of the CONCEPT Trial
INTRODUCTION: The recent CONCEPT study showed that 800 mg/day of pharmaceutical-grade chondroitin sulfate (CS) was superior to placebo and similar to celecoxib in reducing pain and improving function over 6 months in patients with symptomatic knee osteoarthritis (OA). We investigate, in the present...
Autores principales: | Bruyère, Olivier, Dardenne, Nadia, Donneau, Anne-Françoise, Reginster, Jean-Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547984/ https://www.ncbi.nlm.nih.gov/pubmed/32954487 http://dx.doi.org/10.1007/s12325-020-01484-x |
Ejemplares similares
-
Update on the role of pharmaceutical-grade chondroitin sulfate in the symptomatic management of knee osteoarthritis
por: Honvo, Germain, et al.
Publicado: (2019) -
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)
por: Reginster, Jean-Yves, et al.
Publicado: (2017) -
Efficacy of Chondroitin Sulfate in Patients with Knee Osteoarthritis: A Comprehensive Meta-Analysis Exploring Inconsistencies in Randomized, Placebo-Controlled Trials
por: Honvo, Germain, et al.
Publicado: (2019) -
Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment
por: Reginster, Jean-Yves, et al.
Publicado: (2020) -
A systematic review of prediction models to diagnose COVID-19 in adults admitted to healthcare centers
por: Locquet, Médéa, et al.
Publicado: (2021)